HIGHLIGHTS
- who: Salva R. Yurista from the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen , RB, The Netherlands have published the paper: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction, in the Journal: (JOURNAL)
- what: Effect of Apixaban on PAR1 Signalling Pathways Next, the authors aimed to determine whether apixaban influenced the activity of thrombin-related pathways downstream of the PAR1 receptor. The authors demonstrate that treatment with apixaban did not influence LV function, nor did it influence LV dilatation of LV hypertrophy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.